These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 7188124)

  • 1. [Hemocoagulation, fibrinolytic and rheologic parameters in ischemic vasculopathy. Effects of pentoxifylline in the treatment of acute cerebral vasculopathy].
    Muggeo M; Calabrò A; Businaro V; Patussi L; Volpe A; Signorini GP; Crepaldi G
    Ric Clin Lab; 1981; 11 Suppl 1():353-71. PubMed ID: 7188124
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemorheologic conditions in patients with cerebrovascular disease altered by treatment with pentoxifylline.
    Ott E; Lechner H
    Ric Clin Lab; 1981; 11 Suppl 1():253-6. PubMed ID: 7188113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of the effects of pentoxifylline in patients with chronic peripheral circulatory disorders].
    Strano A; Davì G; Novo S; Avellone G; Pinto A
    Ric Clin Lab; 1981; 11 Suppl 1():303-11. PubMed ID: 7188117
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
    Müller R; Lebrach F
    Pharmatherapeutica; 1980; 2(6):372-9. PubMed ID: 7001492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic potential of pentoxifylline. A hemorheologically active drug.
    Schröer RH
    Angiology; 1985 Jun; 36(6):387-98. PubMed ID: 3927788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
    Angelkort B
    Med Welt; 1979 Aug; 30(34):1239-43. PubMed ID: 491921
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebrovascular circulatory disorders: new aspects of pathophysiology and therapy.
    Müller R; Schröer R
    J Med; 1979; 10(5):347-64. PubMed ID: 393790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on platelet aggregation inhibitors in vivo. X. Relationship to thrombolysis.
    Ambrus JL; Ambrus CM; Sharma SD; Suh OW; Gastpar H
    J Med; 1982; 13(5-6):365-71. PubMed ID: 6221055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The biology of fibrinogen. The role of pentoxifylline].
    Soria J; Soria C
    J Mal Vasc; 1989; 14 Suppl A():25-8. PubMed ID: 2654312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorheologic treatment of cerebral reversible ischemic episodes with pentoxifylline--a prospective study.
    Ott E; Körner E; Lechner H
    Angiology; 1988 Jun; 39(6):520-5. PubMed ID: 3377272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline does not interfere with stable coumarin anticoagulant therapy: a clinical study.
    Ingerslev J; Mouritzen C; Stenbjerg S
    Pharmatherapeutica; 1986; 4(9):595-600. PubMed ID: 3763653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of the cerebrovascular action of pentoxifylline].
    Shtok VN; Fedorova NV; Gadanova IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):60-6. PubMed ID: 7064607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rheological efficiency of parenteral pentoxifylline (Trental) in patients with ischemic brain lesions. Preliminary results.
    Schneider R; Schmid-Schönbein H; Kiesewetter H
    Eur Neurol; 1983; 22 Suppl 1():98-104. PubMed ID: 6884407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemorheological, hemocoagulation and photoplethysmographic changes induced by the administration of pentoxifylline in patients with Raynaud's disease].
    Macchione C; Molaschi M; Neirotti M; Garrone MT; Longo F; Pernigotti L
    Minerva Med; 1985 Jul; 76(30-31):1401-5. PubMed ID: 4022431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of pentoxifylline on cerebral ischemia and amino acid incorporation into gerbil brain.
    Cohen MM; Harrison W; Gray R; Becker R
    Trans Am Neurol Assoc; 1979; 104():217-9. PubMed ID: 553415
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications for using trental in the initial manifestations of inadequate blood supply to the brain].
    Eninia GI; Egere DA; Robule VKh; Maĭore IKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(1):50-2. PubMed ID: 3953193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parenteral pentoxifylline treatment of ischemic cerebrovascular accident. Preliminary results].
    Schneider R; Kiesewetter H
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1674-7. PubMed ID: 7140544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H; Kancelarczyk WL; Zebrowski M; Uchman B
    Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological and therapeutic features of cerebral ischemic conditions].
    Lechner H; Schmidt R
    Ric Clin Lab; 1988; 18 Suppl 2():59-64. PubMed ID: 3247563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.